Specialty pharma meets M&A competence INVESTOR RELATIONS Fälligkeitsprofil per 30.06.2019 CHEPLAPHARM Arzneimittel GmbH Ziegelhof 24 17489 Greifswald Germany Tel.: +49 (0) 3834 8539-0 Fax: +49 (0) 3834 8539-119 Internet: www.cheplapharm.com Email: info[at]cheplapharm.com
Welcome message from author
This document is posted to help you gain knowledge. Please leave a comment to let me know what you think about it! Share it to your friends and learn new things together.
Transcript
![Page 1: · ;ul-m ! u m;blb||; t l0 ,b;]; t_o= v u;b=v - t7 $; t : 9 ³ P Q v v J - 9 ³ P Q v v J](https://reader034.cupdf.com/reader034/viewer/2022042218/5ec417f9b07462201f617819/html5/thumbnails/1.jpg)
Specialty pharma meets M&A competence
INVESTOR RELATIONSFälligkeitsprofil per 30.06.2019
CHEPLAPHARM Arzneimittel GmbH Ziegelhof 24 17489 Greifswald Germany Tel.: +49 (0) 3834 8539-0 Fax: +49 (0) 3834 8539-119
Internet: www.cheplapharm.com Email: info[at]cheplapharm.com
![Page 2: · ;ul-m ! u m;blb||; t l0 ,b;]; t_o= v u;b=v - t7 $; t : 9 ³ P Q v v J - 9 ³ P Q v v J](https://reader034.cupdf.com/reader034/viewer/2022042218/5ec417f9b07462201f617819/html5/thumbnails/2.jpg)
INVESTOR RELATIONS
CHEPLAPHARM Arzneimittel GmbH Ziegelhof 24 17489 Greifswald Germany Tel.: +49 (0) 3834 8539-0 Fax: +49 (0) 3834 8539-119
Internet: www.cheplapharm.com Email: info[at]cheplapharm.com
980
0
200
400
600
800
1000
1200
2019 2020 2021 2022 2023 2024 2025
In M
illio
n EU
RFÄLLIGKEITSPROFIL 2019-2025 per 30.06.2019
Revolving Credit Facility Term Loan B
980
![Page 3: · ;ul-m ! u m;blb||; t l0 ,b;]; t_o= v u;b=v - t7 $; t : 9 ³ P Q v v J - 9 ³ P Q v v J](https://reader034.cupdf.com/reader034/viewer/2022042218/5ec417f9b07462201f617819/html5/thumbnails/3.jpg)
OFFICE Germany
CHEPLAPHARM Arzneimittel GmbH
Ziegelhof 24
17489 Greifswald
Tel.: +49 (0) 3834 8539-0
Fax: +49 (0) 3834 8539-119
Internet: www.cheplapharm.com
Email: info[at]cheplapharm.com
CONTACT US
CHEPLAPHARM Arzneimittel GmbH Ziegelhof 24 17489 Greifswald Germany Tel.: +49 (0) 3834 8539-0 Fax: +49 (0) 3834 8539-119
Internet: www.cheplapharm.com Email: info[at]cheplapharm.com
IR KONTAKT Germany
CHEPLAPHARM Arzneimittel GmbH
Ziegelhof 24
17489 Greifswald
Jens Remmers
Head of Investor Relations
Tel.: +49 (0) 3834 8539-145
Email: investor-relations[at]cheplapharm.com
Related Documents
![· 0˛< ˛ d˘ 3< ˘ ˛ v =˘ ˚ ˛ % ... ˛v r ) *’ ˜ ˛ c ˛ k :aa @˛ q ] 0˛ q ] hhb˛ q ˛ ˘˛ q ] ˙c˛‘ ) ˆ > q (k q+ c˛ mˆq %] b ˜ q ] b˛) 08 k +a ˘ˆ[*](https://static.cupdf.com/doc/110x72/5eac74867ccd34079d195c6e/0-d-3-v-v-r-a-oe-c-k-aa-q.jpg)
![s v { s q s y q v s v s y ~ } x | { z y x s w s v u q t s r ] q p b a ` ^ ] · 2017-10-29 · s v { s q s y q v s v s y ~ } x | { z y x s w s v u q t s r ] q p b a ` ^ ] ... f](https://static.cupdf.com/doc/110x72/5e805af60200d41ee21595ea/s-v-s-q-s-y-q-v-s-v-s-y-x-z-y-x-s-w-s-v-u-q-t-s-r-q-p-b-a-2017-10-29.jpg)
